Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Readies for the Next Phase of Growth with the Appointment of Neha Krishnamohan as CFO and EVP, Corporate Development and Promotion of Jennifer Bush to Chief Operating Officer
Read Article
News
2024
2023
Archive
Search news articles
March 1, 2018
PEAR THERAPEUTICS TO COLLABORATE WITH NOVARTIS TO DEVELOP PRESCRIPTION DIGITAL THERAPEUTICS
February 13, 2018
NOHLA THERAPEUTICS INITIATES GLOBAL LAUNCH PHASE 2 TRIAL OF NLA101 IN PATIENTS WITH AML
February 12, 2018
AUDENTES THERAPEUTICS ANNOUNCES DOSING OF FIRST PATIENT IN VALENS, A PHASE 1/2 CLINICAL TRIAL OF AT342 FOR THE TREATMENT OF CRIGLER-NAJJAR SYNDROME
February 7, 2018
IMPEL NEUROPHARMA ANNOUNCES POSITIVE RESULTS OF PHASE 1 CLINICAL TRIAL OF INP104 FOR TREATMENT OF ACUTE MIGRAINE HEADACHE
February 7, 2018
SCIENTIST.COM ADDS ACCOMPLISHED PHARMA EXECUTIVE ARNE BRANDON TO MANAGEMENT TEAM
February 7, 2018
AUDENTES THERAPEUTICS ANNOUNCES SELECTION OF OPTIMIZED CLINICAL DEVELOPMENT CANDIDATE FOR POMPE DISEASE PROGRAM
February 1, 2018
CHRONO THERAPEUTICS ANNOUNCES APPOINTMENT OF DAVID HAPPEL AS CHIEF EXECUTIVE OFFICER
February 1, 2018
CETERIX ANNOUNCES COMPLETION OF GROUNDBREAKING STUDY OF REPAIR FOR MENISCAL TEARS PREVIOUSLY THOUGHT UNREPAIRABLE
January 29, 2018
AUDENTES THERAPEUTICS ANNOUNCES THE CLOSING OF ITS PUBLIC OFFERING AND FULL EXERCISE OF THE UNDERWRITERS’ OPTION TO PURCHASE ADDITIONAL SHARES
January 25, 2018
AUDENTES THERAPEUTICS ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK
« Previous Page
1
…
7
8
9
10
Next Page »